Regis Healthcare Ltd (ASX: REG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Regis Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.89 billion
P/E Ratio 51.85
Dividend Yield 2.65%
Shares Outstanding 302.36 million
Earnings per share 0.125
Dividend per share 0.18
Year To Date Return -8.78%
Earnings Yield 1.93%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Regis Healthcare Ltd (ASX: REG)
Latest News

ASX aged care shares
Share Market News

Regis Healthcare (ASX:REG) share price down despite paying a HY21 dividend

The Regis Healthcare Ltd (ASX:REG) share price is currently down after announcing its FY21 half-year result. It also declared a…

Read more »

red arrow pointing down, falling share price
Share Fallers

Why Frontier Digital Ventures, JB Hi-Fi, Regis, & Tyro are dropping lower

Frontier Digital Ventures Ltd (ASX:FDV) and Tyro Payments Ltd (ASX:TYR) shares are two of four dropping notably lower on Wednesday...

Read more »

asx share price falling represented by graph of paper plane trending down
Share Fallers

Here's why the Regis Healthcare (ASX:REG) share price is crashing 11% lower

The Regis Healthcare Ltd (ASX:REG) share price has come under pressure on Wednesday after an update on its takeover approach...

Read more »

ASX share price on watch represented by surprised man with binoculars
Share Market News

Why the Summerset (ASX:SNZ) share price is in focus today

The Summerset Group Holdings Ltd (ASX: SNZ) share price is one to watch after a record quarterly sales result for…

Read more »

shares lower
Share Fallers

Why Afterpay, DEXUS, Integrated Research, & Regis Healthcare are dropping lower

Afterpay Ltd (ASX:APT) and Integrated Research Limited (ASX:IRI) shares are two of four dropping lower today...

Read more »

a woman
Share Market News

ASX 200 ends flat on Friday

The S&P/ASX 200 Index (ASX:XJO) ended flat today. A highlight was the news of a partnership between Mesoblast Limited (ASX:MSB)…

Read more »

jump in asx share price represented by man jumping in the air in celebration
Share Market News

ASX stock of the day: Japara Healthcare (ASX:JHC) share price soars 23%

Japara Healthcare Ltd (ASX: JHC) shares have rocketed more than 20% today. Here's why the aged care sector is in…

Read more »

Share Fallers

Why Kogan, Oil Search, Orica, & Soul Pattinson shares are dropping lower

Kogan.com Ltd (ASX:KGN) and Oil Search Limited (ASX:OSH) shares are two of four that are dropping notably lower on Friday...

Read more »

beat the share market
Share Gainers

Why Accent, Mesoblast, Redbubble, & Regis Healthcare shares are charging higher

Mesoblast limited (ASX:MSB) and Regis Healthcare Ltd (ASX:REG) shares are two of four charging notably higher on Friday. Here's why...

Read more »

Transurban share price ASX shares upgrade to buy asx 200 share price upgrade to buy represented by hand drawing line under the word upgrade
Mergers & Acquisitions

Takeover battle for Regis (ASX:REG) share price triggers sector-wide upgrade

The takeover bid of the Regis Healthcare Ltd (ASX: REG) share price triggered a re-rating with JP Morgan upgrading the…

Read more »

Mergers & Acquisitions

Washington H. Soul Pattinson (ASX:SOL) launches Regis Healthcare (ASX:REG) takeover

Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) has made an approach to takeover Regis Healthcare Ltd (ASX:REG)...

Read more »

ASX Small Caps
Share Market News

Broker picks best ASX small cap stocks to buy from the reporting season

ASX small caps have delivered better FY20 results than their bigger counterparts, but which of these emerging stocks can keep…

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
12 Mar 2026 $0.0900 100.00% Interim 09 Apr 2026
09 Sep 2025 $0.0813 69.99% Final 24 Sep 2025
13 Mar 2025 $0.0809 59.95% Interim 10 Apr 2025
10 Sep 2024 $0.0664 50.00% Final 25 Sep 2024
14 Mar 2024 $0.0628 50.00% Interim 11 Apr 2024
12 Sep 2023 $0.0748 50.00% Final 27 Sep 2023
16 Mar 2023 $0.0200 50.00% Interim 14 Apr 2023
15 Sep 2022 $0.0232 50.00% Final 30 Sep 2022
10 Mar 2022 $0.0352 50.00% Interim 08 Apr 2022
15 Sep 2021 $0.0463 50.11% Final 30 Sep 2021
10 Mar 2021 $0.0200 50.00% Interim 08 Apr 2021
11 Mar 2020 $0.0402 50.00% Interim 30 Sep 2020
11 Sep 2019 $0.0711 100.00% Final 26 Sep 2019
13 Mar 2019 $0.0812 100.00% Interim 11 Apr 2019
11 Sep 2018 $0.0865 100.00% Final 26 Sep 2018
13 Mar 2018 $0.0928 100.00% Interim 11 Apr 2018
01 Sep 2017 $0.0000 100.00% Final 18 Sep 2017
03 Mar 2017 $0.1030 100.00% Interim 20 Mar 2017
02 Sep 2016 $0.0594 100.00% Final 19 Sep 2016
03 Mar 2016 $0.0940 100.00% Interim 21 Mar 2016
03 Mar 2004 $0.0700 100.00% Interim 24 Mar 2004

REG ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Regis Healthcare Ltd

Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.

REG Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
20 Mar 2026 $6.25 $0.31 5.22% 2,316,251 $5.94 $6.25 $5.80
19 Mar 2026 $5.94 $-0.25 -4.04% 354,334 $6.10 $6.10 $5.94
18 Mar 2026 $6.19 $0.00 0.00% 312,170 $6.20 $6.41 $6.14
17 Mar 2026 $6.19 $-0.07 -1.12% 466,457 $6.20 $6.33 $6.08
16 Mar 2026 $6.26 $0.06 0.97% 168,323 $6.31 $6.34 $6.22
13 Mar 2026 $6.20 $-0.26 -4.02% 338,022 $6.36 $6.42 $6.17
12 Mar 2026 $6.46 $-0.31 -4.58% 953,484 $6.80 $6.80 $6.37
11 Mar 2026 $6.77 $0.08 1.20% 329,931 $6.69 $6.77 $6.58
10 Mar 2026 $6.69 $0.16 2.45% 716,526 $6.45 $6.69 $6.45
09 Mar 2026 $6.53 $-0.25 -3.69% 627,212 $6.75 $6.75 $6.45
06 Mar 2026 $6.78 $0.05 0.74% 571,218 $6.86 $6.86 $6.58
05 Mar 2026 $6.73 $-0.17 -2.46% 1,638,913 $6.80 $6.92 $6.66
04 Mar 2026 $6.90 $-0.12 -1.71% 395,410 $6.86 $6.96 $6.72
03 Mar 2026 $7.02 $0.05 0.72% 303,211 $7.04 $7.06 $6.93
02 Mar 2026 $6.97 $0.02 0.29% 422,306 $7.00 $7.08 $6.89
27 Feb 2026 $6.95 $-0.02 -0.29% 483,884 $6.97 $7.06 $6.94
26 Feb 2026 $6.97 $0.15 2.20% 413,839 $6.93 $7.10 $6.87
25 Feb 2026 $6.82 $-0.03 -0.44% 303,507 $6.90 $7.06 $6.81
24 Feb 2026 $6.85 $-0.08 -1.15% 373,642 $7.19 $7.19 $6.85
23 Feb 2026 $6.93 $0.49 7.61% 938,526 $6.60 $7.20 $6.57
20 Feb 2026 $6.44 $-0.01 -0.16% 432,761 $6.36 $6.44 $6.31
19 Feb 2026 $6.45 $-0.05 -0.77% 366,145 $6.50 $6.54 $6.38

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
25 Feb 2026 Carmel Monaghan Buy 2,200 $15,164
On-market trade.
03 Dec 2025 Linda Mellors Issued 115,236 $916,126
Issue of securities. 629,324 Rights. No cash consideration is payable. 115,236 Performance Rights issued under the FY26 LTI plan.
17 Oct 2025 Linda Mellors Cancelled 4,688 $30,237
Cancellation of securities. 514,088 Rights
13 Oct 2025 Linda Mellors Exercise 419,690 $2,736,378
Conversion of securities. 5,05,020 Rights
13 Oct 2025 Linda Mellors Issued 419,690 $2,736,378
Conversion of securities.
13 Oct 2025 Linda Mellors Issued 13,756 $89,689
Conversion of securities. 518,776 Rights
02 Sep 2025 Sally Freeman Buy 4,805 $37,440
On-market trade.
29 Aug 2025 Graham Hodges Buy 22,000 $170,588
On-market trade.
29 Aug 2025 Graham Hodges Transfer 110,000 $863,500
Off-market transfer. Assuming off market transfer of shares
29 Aug 2025 Graham Hodges Transfer 110,000 $863,500
Off-market transfer. Assuming off market transfer of shares
27 Aug 2025 Jodie Leonard Buy 12,500 $98,750
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Graham Hodges Non-Executive DirectorNon-Executive Chairman Aug 2017
Mr Hodges has international experience in the financial services industry with a career spanning more than 40 years. He commenced his career in Commonwealth Treasury, Canberra, where he worked for approximately 10 years before being seconded to the International Monetary Fund in Washington for several years. He built an executive career at the Australian and New Zealand Banking Group Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. He is currently a Non-Executive Director of Assemble Holdco 1 Pty Ltd and Non Executive Director of Australia and New Zealand Banking Group Limited and ANZ BH Pty Ltd. He was previously Chair of ANZ SAM Board, Esanda, and ANZ Wealth, a Director of AmBank Holdings Berhad and a member of the Australian Governments Aged Care Financing Authority. He is Member of the People and Risk and Compliance Committee.
Professor Christine Constance Bennett Non-Executive Director Mar 2018
Professor Bennett has over 30 years of health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. She was awarded the title of Emeritus Professor at the University of Notre Dame Australia following her contributions as Deputy Vice Chancellor Enterprise & Partnerships and Dean of Medicine, Sydney for more than 10 years. Previously, she was Chair of Research Australia, a Group Executive and Chief Medical Officer at both MBF Limited and Bupa Australia, a Partner in the KPMG Health and Life Sciences Practice, CEO of Westmead Hospital, Chair of the Sydney Childrens Hospitals Network, Chair of the National Health and Hospitals Reform Commission, Non-Executive Director of Digital Health CRC Limited and on the Telstra Health Board. She is currently a Non Executive Director of Sonic Healthcare Ltd, Patron of Research Australia, on the Board of the Australian Digital Health Agency, and Convenor of the Champions of Change STEM and Health Group for gender equality. He was awarded an Officer of the Order of Australia in 2014, in recognition of her distinguished service to medicine and health care leadership. She is Chair of the Clinical Governance and Care Committee and Member of the Risk and Compliance Committee and Member of the Property Committee.
Mr Ian Gregory Roberts Non-Executive Director May 2007
Mr Roberts was a Director of Regis upon listing on 7 October 2014. Prior to listing, he had been a Director of Fairway Investment Holdings Pty Ltd1 since May 2007. Before co leading the Regis journey, he was involved in property development in South East Queensland. As a founding shareholder and Director of Regis, he headed up Property with oversight of the development and implementation of the strategy that saw the business grow to more than 4,500 beds nationally. He has over 35 years of experience in the real estate sector including more than 25 years in residential aged care. He is currently a Non Executive Director of several property and property services enterprises. He is Chair of Property Committee and Member of the People Committee.
Ms Jodie Lee Leonard Non-Executive Director Nov 2023
Ms Leonard is an experienced listed company director and commercial leader with a focus on strategic marketing and digital transformation. Her career spans over 30 years in ASX, NYSE and FTSE listed companies and includes senior positions at General Electric, the Nine Network, British Airways and Telstra, having worked across Australia, the USA, UK, Asia and Europe. She has experience in a diverse range of industries including banking and financial services, superannuation, healthcare, technology, consumer goods, media and entertainment, and travel and tourism. She currently sits on the board of Barwon Water Corporation. She has previously served on the boards of Pacific Smiles Group Ltd, Beyond Bank Australia, the RACV, Flexigroup and BWX. She is actively involved with Women on Boards and Chairs the NED Circle syndicate. She is Chair of the People Committee and Member of the Property Committee and Clinical Governance Committee
Dr Linda Jane Mellors Chief Executive OfficerManaging Director Aug 2019
Dr Mellors has been a chief executive for almost 15 years with broad experience in health and aged care, including substantial growth and transformation execution. She is a Director of Ageing Australia and is a member of the Finance and Risk Management Committee. She is also a Board Director of Mercy Community Services Ltd and its subsidiaries including Mackillop Family Services, and a member of the Governance Committee. She was formerly Chair of the Aged Care Reform Network, the Aged Care Guild, and the North Eastern Metropolitan Integrated Cancer Service, Co Chair of the Victorian Metropolitan Hospital Chief Executive group, Board Member of the Parent Infant Research Institute and Board Director of the South West Melbourne Medicare Local. She is also a Fellow of the Williamson Community Leadership Program and a member of Chief Executive Women. She is Member of the Property Committee.
Ms Sally Margaret Freeman Non-Executive Director Jan 2022
Ms Freeman chairs Regis Audit, Risk and Compliance Committee. She has experience in governance, risk and audit, with an executive career spanning 30 years, culminating in being the Partner in Charge of KPMG Australias Risk Consulting practice and a member of KPMGs Global Risk Executive. She is currently a Non Executive Director at Eastern Health, Regional Investment Corporation, Melbourne Football Club, Suburban Rail Loop Authority and ASX listed Netwealth Group Limited, Netwealth Superannuation Services Pty Ltd. She was previously Director of Aioi Nissay Dowa Insurance Company Australia Pty Ltd and was the Chair of their Board. She is a member of Chief Executive Women. She is Chair of the Risk and Compliance Committee and Member of the People and Clinical Governance and Care Committee.
Ms Carmel Anne Monaghan Non-Executive Director Feb 2026
Ms Monaghan is a healthcare executive with over 30 years in the healthcare sector. She was the CEO of Ramsay Health Care Australia until July 2025 and has experience and a understanding of healthcare operations and strategy both in Australia and overseas. Carmel is currently a Non-Executive Director and Chair of the Remuneration Committee at EMVision Medical Devices (ASX:EMV) and has served on boards including Ramsay Sante (France) and the Australian Private Hospitals Association.
Mr Malcolm Peter Ross Company SecretaryGeneral Counsel Nov 2021
-
Rick Rostolis Chief Financial Officer
-
Malcolm Peter Ross Company SecretaryGeneral Counsel
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Galabay Pty Ltd Acn 010 849 153 81,910,479 27.19%
Hsbc Custody Nominees (Australia) Limited 57,904,128 19.22%
Citicorp Nominees Pty Limited 45,843,568 15.22%
Ashburn Pty Ltd Acn 005 883 438 32,205,238 10.69%
J P Morgan Nominees Australia Pty Limited 30,127,423 10.00%
UBS Nominees Pty Ltd 4,928,417 1.64%
BNP Paribas Noms Pty Ltd 3,658,466 1.21%
Mandala Holdings Pty Ltd 3,180,000 1.06%
Warbont Nominees Pty Ltd 1,940,289 0.64%
HSBC Custody Nominees (Australia) Limited A/C 2 1,912,254 0.63%
Bki Investment Company Limited 1,807,428 0.60%
Galabay Pty Ltd Acn 010 849 153 1 1,751,468 0.58%
National Nominees Limited 1,629,406 0.54%
Neweconomy Com Au Nominees Pty Limited 1,596,153 0.53%
Mr Vincent Michael O'Sullivan 1,492,000 0.50%
Merrill Lynch (Australia) Nominees Pty Limited 1,381,610 0.46%
HSBC Custody Nominees (Australia) Limited Gsco Eda 1,363,526 0.45%
BNP Paribas Noms Pty Ltd 1 1,270,629 0.42%
BNP Paribas Nominees Pty Ltd 1,106,128 0.37%
HSBC Custody Nominees (Australia) Limited 1 1,057,128 0.35%

Profile

since

Note